Join Growin Stock Community!

神州-DR910861.TW Overview

TW StockElectronics
(No presentation for 910861)
My Watchlist

Ticker

Value

empty

There is no following symbol in this watchlist.

神州-DR（910861）Overall Performance

神州-DR（910861）AI Analysis & Strategy

AI Strategy

Browsing restrictions can be lifted for a fee.

神州-DR（910861） PowerScanner

Introduction >>

Power Squeeze

Surfing Trend

1 Day

1 Week

1 Month

神州-DR（910861）Key Information

神州-DR（910861）Profile

Digital China Holdings Limited, an investment holding company, provides big data products and solutions for government and enterprise customers primarily in Mainland China. The Big Data Products and Solutions segment sells data software products focused on spatial-temporal big data and artificial intelligence. This segment offers data fabric comprising Yan Cloud DaaS, a software platform that supports data sharing, interoperability, and integration of isolated digital islands; and Sysnet, an integration platform that integrates various data, applications, and services. It also provides data hub, including data management, security, innovation, and aggregation products; and digital twin, which constructs a digital replica of the physical city, as well as data solutions for city and supply chain digital native transformation, and fintech. The Software and Operating Services segment offers end-to-end data-enabled supply chain operating services, as well as software development, testing, operation, and maintenance services. The Traditional Services segment provides systems integration services, e-commerce supply chain services, and software and operating services. The segment also engages in the investments, property sales and rental, and other businesses. It also engages in provision of logistics, systems integration, technical, network optimization, rural agricultural internet, data processing and manpower outsourcing, and cloud application system services; development and construction of science and technology park; finance lease and property development business; operation of sm@rt city platform; and sale of financial specialized equipment and surveying service software. In addition, the company offers Quattro, a touchless multi-biometric access control reader; and Aibion Trio, a contactless multi-biometric access control solution. Digital China Holdings Limited was incorporated in 2000 and is headquartered in Wan Chai, Hong Kong.

神州-DR（910861）FAQ

This disclaimer is provided by TradingValley Inc. and includes any messages, news, research, analysis, prices or other information provided by the Company's website, the application "Growin App" and other services provided through the Company's website. It is only general market information for educational and investment decision-making reference, and does not constitute any investment advice. View Growin Disclaimer

METRIC
VALUE
vs. INDUSTRY
EPS (TTM)
-185.12
PE Ratio (TTM)
-
Forward PE
16.00
PS Ratio (TTM)
0.00
PB Ratio
0.00
Price-to-FCF
-
METRIC
VALUE
vs. INDUSTRY
Gross Margin
15.08%
Net Margin
-3.97%
Revenue Growth (YoY)
7.53%
Profit Growth (YoY)
-8.31%
3-Year Revenue Growth
4.98%
3-Year Profit Growth
-2.75%
METRIC
VALUE
vs. INDUSTRY
EPS (TTM)
-185.12
PE Ratio (TTM)
-
Forward PE
16.00
PS Ratio (TTM)
0.00
PB Ratio
0.00
Price-to-FCF
-
Gross Margin
15.08%
Net Margin
-3.97%
Revenue Growth (YoY)
7.53%
Profit Growth (YoY)
-8.31%
3-Year Revenue Growth
4.98%
3-Year Profit Growth
-2.75%
default symbol

910861

神州-DR

5.12D

-1.56%

(-0.02)

  • When is 910861's latest earnings report released?

    The most recent financial report for 神州-DR (910861) covers the period of 2024Q2 and was published on 2024/06/30. This report is prepared according to IFRS/US GAAP standards and includes key financial indicators—Revenue, Profitability, Cash Flow, and Capital Structure. This information is essential for investors evaluating 910861's short-term business performance and financial health. For the latest updates on 910861's earnings releases, visit this page regularly.

  • What is the operating profit of 910861?

    According to the latest financial report, 神州-DR (910861) reported an Operating Profit of -402.67M with an Operating Margin of -1.28% this period, representing a decline of 236.7% compared to the same period last year. Operating Profit reflects the company's core business efficiency and cost control, making it a key indicator for evaluating operational strength and profitability.

  • How is 910861's revenue growth?

    In the latest financial report, 神州-DR (910861) announced revenue of 31.42B, with a Year-Over-Year growth rate of 18.33%. Revenue growth can be driven by product mix changes, market share expansion, price adjustments, or international market penetration. Investors should also monitor gross margin and regional revenue distribution for a comprehensive view of growth quality and sustainability.

  • How much debt does 910861 have?

    As of the end of the reporting period, 神州-DR (910861) had total debt of 0, with a debt ratio of 0.57. Short-term debt comprises a higher/lower proportion. The level of financial leverage directly impacts the company's capital structure and interest coverage. If debt is high, pay attention to interest expenses and refinancing risks. Conversely, a low-leverage structure indicates greater risk tolerance but potentially less growth flexibility.

  • How much cash does 910861 have?

    At the end of the period, 神州-DR (910861) held Total Cash and Cash Equivalents of 8.73B, accounting for 0.1 of total assets. Both current and quick ratios indicate robust short-term debt repayment ability. High cash reserves typically mean the company has strong liquidity, supporting operational needs, expansion investments, or shareholder returns.

  • Does 910861 go with three margins increasing?

    In the latest report, 神州-DR (910861) did not achieve the “three margins increasing” benchmark, with a gross margin of 13.86%%, operating margin of -1.28%%, and net margin of -1.19%%. This demonstrates limited improvement in profitability, which is a key signal for fundamental analysis. Investors should consider margin trends alongside other financial indicators to assess 910861's profit trajectory and future growth potential.

  • Is 910861's EPS continuing to grow?

    According to the past four quarterly reports, 神州-DR (910861)'s earnings per share (EPS) shows a steady growth trend, with the latest EPS at -0.07. If EPS continues to rise due to revenue growth and cost optimization, it can support P/E valuation recovery and attract long-term investors.

  • What is the FCF of 910861?

    神州-DR (910861)'s Free Cash Flow (FCF) for the period is 888.96M, calculated as Operating Cash Flow minus Capital Expenditures, representing a fall of 45.99% compared with the previous period. Positive FCF growth provides stable funding for dividends, debt repayment, or strategic acquisitions, and is an important measure of true profitability and shareholder return potential.